2018
DOI: 10.1016/j.ad.2017.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…Eleven papers comparing histopathological results between biopsies and complete excision of keratinocyte carcinoma (BCC, SCC or both), via conventional surgery [1][2][3][4][5][6][7] or MMS, [8][9][10][11] were analysed. A supplementary study evaluating the incidence of BCC with mixed histopathological subtypes in MMS surgical sections was included.…”
Section: Literature Reviewmentioning
confidence: 99%
See 3 more Smart Citations
“…Eleven papers comparing histopathological results between biopsies and complete excision of keratinocyte carcinoma (BCC, SCC or both), via conventional surgery [1][2][3][4][5][6][7] or MMS, [8][9][10][11] were analysed. A supplementary study evaluating the incidence of BCC with mixed histopathological subtypes in MMS surgical sections was included.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Several series have compared histopathological findings between the biopsy and the final excision, either via conventional surgery 1‐7 or Mohs micrographic surgery (MMS) 8‐11 . However, the objectives and methodology vary between studies and results are difficult to compare.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…One study found that 21.1% of biopsies under diagnosed the aggressiveness of BCCs and SCCs when compared with subsequent MMS pathology samples, owing to the heterogeneity of many tumors and lack of complete tumor visualization with biopsy (Izikson et al., 2010). Therefore, if the overall pathology or base of the tumor differs from the pathology of the biopsy sample, this may affect risk stratification and reduce treatment success (Bartoš and Kullová, 2016, Cortés-Peralta et al., 2018, Sexton et al., 1990).…”
Section: Superficial Ablative Proceduresmentioning
confidence: 99%